Brio Consultants LLC Increases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Brio Consultants LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 75.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 751 shares of the healthcare conglomerate’s stock after purchasing an additional 324 shares during the period. Brio Consultants LLC’s holdings in UnitedHealth Group were worth $393,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of UNH. Citizens National Bank Trust Department grew its holdings in shares of UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after acquiring an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH grew its holdings in shares of UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after acquiring an additional 1,465 shares during the period. Sherbrooke Park Advisers LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $515,000. Full Sail Capital LLC grew its stake in shares of UnitedHealth Group by 2.1% in the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock worth $815,000 after buying an additional 33 shares during the last quarter. Finally, Soros Fund Management LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $39,413,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, CEO Stephen J. Hemsley acquired 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The stock was purchased at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer directly owned 679,493 shares of the company’s stock, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares of the company’s stock, valued at $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders bought a total of 109,408 shares of company stock worth $31,607,768 over the last three months. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Trading Up 0.4%

NYSE:UNH opened at $282.13 on Tuesday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market capitalization of $255.93 billion, a price-to-earnings ratio of 11.81, a price-to-earnings-growth ratio of 1.39 and a beta of 0.45. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The business has a fifty day moving average price of $300.91 and a 200-day moving average price of $422.56.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 3.13%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group’s dividend payout ratio is 37.02%.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Erste Group Bank downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th. KeyCorp cut their price target on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating on the stock in a research note on Monday, June 2nd. Barclays reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. TD Securities reaffirmed a “hold” rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Truist Financial lowered their price objective on UnitedHealth Group from $360.00 to $345.00 and set a “buy” rating on the stock in a research report on Wednesday, July 16th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $392.29.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.